Radiopharm Theranostics (RADX)

• Market cap: $34.1M
• 1 day: -7.16%
• 5 days: -7.8%
• 1 month: -12.8%
• 3 months: -5.41%
• 6 months: -26.91%
• Year to date: -22.09%
• 1 year: -14.47%
• 5 years: -77.25%
• 10 years: -77.25%
• Sector: Healthcare
• Industry: Biotechnology

About: Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.

Employees: 14